Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDER'S EQUITY

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDER'S EQUITY - USD ($)
$ in Thousands
Total
Follow On Offering
At The Market
Common Stock
Common Stock
Follow On Offering
Common Stock
At The Market
Additional Paid-In Capital
Additional Paid-In Capital
Follow On Offering
Additional Paid-In Capital
At The Market
Accumulated Other Comprehensive (Loss) Gain
Accumulated Deficit
Balance at Dec. 31, 2019 $ 79,184     $ 43     $ 372,100     $ 24 $ (292,983)
Balance (in shares) at Dec. 31, 2019       43,367,801              
Exercise of stock options 509           509        
Exercise of stock options, Shares       95,647              
Vesting of restricted stock units       105,912              
Issuance of shares under Employee Stock Purchase Plan 223           223        
Issuance of shares under Employee Stock Purchase Plan, Shares       36,708              
Stock-based compensation expense 7,909           7,909        
Issuance of common stock / preferred stock, warrants, net of issuance costs     $ 11,919     $ 2     $ 11,917    
Issuance of common stock / preferred stock, net of issuance costs (in shares)           2,201,810          
Issuance of warrants 128           128        
Other comprehensive gain (loss) (24)                 (24)  
Net loss (53,908)                   (53,908)
Balance at Sep. 30, 2020 45,940     $ 45     392,786       (346,891)
Balance (in shares) at Sep. 30, 2020       45,807,878              
Balance at Dec. 31, 2019 79,184     $ 43     372,100     24 (292,983)
Balance (in shares) at Dec. 31, 2019       43,367,801              
Net loss (84,000)                    
Balance at Dec. 31, 2020 $ 90,553     $ 56     467,518       (377,021)
Balance (in shares) at Dec. 31, 2020 56,222,746     56,222,746              
Balance at Jun. 30, 2020 $ 62,406     $ 45     389,766       (327,405)
Balance (in shares) at Jun. 30, 2020       45,758,881              
Exercise of stock options 297           297        
Exercise of stock options, Shares       46,547              
Vesting of restricted stock units       2,450              
Stock-based compensation expense 2,723           2,723        
Net loss (19,486)                   (19,486)
Balance at Sep. 30, 2020 45,940     $ 45     392,786       (346,891)
Balance (in shares) at Sep. 30, 2020       45,807,878              
Balance at Dec. 31, 2020 $ 90,553     $ 56     467,518       (377,021)
Balance (in shares) at Dec. 31, 2020 56,222,746     56,222,746              
Exercise of stock options $ 157           157        
Exercise of stock options, Shares 20,134     20,134              
Vesting of restricted stock units       267,012              
Issuance of shares under Employee Stock Purchase Plan $ 153           153        
Issuance of shares under Employee Stock Purchase Plan, Shares       33,058              
Stock-based compensation expense 7,479           7,479        
Issuance of common stock / preferred stock, warrants, net of issuance costs   $ 70,468     $ 5     $ 70,463      
Issuance of common stock / preferred stock, net of issuance costs (in shares)         5,400,000            
Other comprehensive gain (loss) (5)                 (5)  
Net loss (62,745)                   (62,745)
Balance at Sep. 30, 2021 $ 106,060     $ 61     545,770     (5) (439,766)
Balance (in shares) at Sep. 30, 2021 61,942,950     61,942,950              
Balance at Jun. 30, 2021 $ 129,977     $ 61     543,674     (19) (413,739)
Balance (in shares) at Jun. 30, 2021       61,920,250              
Vesting of restricted stock units       22,700              
Stock-based compensation expense 2,096           2,096        
Other comprehensive gain (loss) 14                 14  
Net loss (26,027)                   (26,027)
Balance at Sep. 30, 2021 $ 106,060     $ 61     $ 545,770     $ (5) $ (439,766)
Balance (in shares) at Sep. 30, 2021 61,942,950     61,942,950